Ascendis Pharma A/S (ASND) Stock Price Today
Aura AI Summary
Key Stats
- $16.52BMarket Cap
- -Volume
- HealthSector
- $277.1852W High
- $166.7852W Low
- -Typical Hold Time
- $16.89BEnterprise Value
- -Div Yield
- -Trading Activity
Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $166.78 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Most Recent News
Inno Holdings resumes Nasdaq trading after a halt with no new material developments.
Inno Holdings Inc. announced that its common stock will resume trading on The Nasdaq Capital Market starting July 31, 2026, after a trading halt was imposed on June 12, 2026, due to unusual trading activities. The company stated it is unaware of any ...

ZenaTech's drone services enter a booming Canadian oil market with $500B+ investments and rising oil prices.
ZenaTech has expanded its drone services for the Canadian oil and gas sector by acquiring Velocity Geomatics, entering a market boosted by a 45% rise in oil prices and over $500 billion in expected investments over the next decade. This growth suppor...

VINCI reports 2026 half-year financial results with 2% revenue growth and strong earnings.
VINCI published its half-year financial report for 2026, highlighting a 2% increase in revenue, including 4% growth in the second quarter. The company also reported a 4% rise in EBITDA and significant growth in earnings per share, reflecting strong o...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.